Valuation Carasent ASA OTC Markets
Stocks
APXZF
NO0010123060
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 07-03 | Calendar Monday, July 6 - Friday, July 10 | FW |
| 06-18 | Affärsvärlden lists seven stocks to daydream about over the Midsummer holiday | FW |
Company Valuation: Carasent ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,908 | 4,081 | 3,825 | 1,653 | 2,096 | 1,661 | - | - |
| Change | - | 4.4% | -6.27% | -56.77% | 26.8% | -20.76% | - | - |
| Enterprise Value (EV) 1 | 3,041 | 3,422 | 3,501 | 1,431 | 1,982 | 1,626 | 1,550 | 1,449 |
| Change | - | 12.53% | 2.31% | -59.13% | 38.49% | -17.96% | -4.68% | -6.49% |
| P/E | - | - | - | -39.7x | 54.9x | 64.3x | 29.4x | 19.1x |
| PBR | - | - | - | 1.8x | - | 2.11x | 1.97x | 1.79x |
| PEG | - | - | - | - | -0x | -2.5x | 0x | 0.4x |
| Capitalization / Revenue | 28.5x | 20.9x | 15.7x | 6.01x | 5.71x | 4x | 3.29x | 2.91x |
| EV / Revenue | 22.2x | 17.5x | 14.3x | 5.2x | 5.4x | 3.92x | 3.06x | 2.53x |
| EV / EBITDA | 66.9x | 74x | 164x | 33.9x | 25.3x | 16.7x | 10.6x | 7.9x |
| EV / EBIT | 116x | 181x | -169x | -129x | 197x | 57.5x | 21.4x | 13x |
| EV / FCF | -32.8x | -48.2x | -58.4x | -17.4x | -171x | 27.4x | 20x | 15.2x |
| FCF Yield | -3.05% | -2.07% | -1.71% | -5.75% | -0.58% | 3.65% | 5% | 6.6% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | - | -0.5588 | 0.5 | 0.37 | 0.81 | 1.245 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 137.1 | 195.3 | 244 | 275.3 | 366.9 | 415 | 505.7 | 571.8 |
| EBITDA 1 | 45.47 | 46.26 | 21.31 | 42.2 | 78.26 | 97.4 | 145.6 | 183.4 |
| EBIT 1 | 26.13 | 18.9 | -20.68 | -11.1 | 10.06 | 28.29 | 72.55 | 111.2 |
| Net income 1 | 0.642 | 31.17 | -46.44 | -42.26 | 37 | 26.21 | 57.28 | 88.35 |
| Net Debt 1 | -867.4 | -658.4 | -323.7 | -222.4 | -114.8 | -35.41 | -111.5 | -212.2 |
| Reference price 3 | 47.90 | 47.90 | 47.90 | 22.20 | 27.45 | 23.80 | 23.80 | 23.80 |
| Nbr of stocks (in thousands) | 78,618 | 79,621 | 79,621 | 72,325 | 69,940 | 68,469 | - | - |
| Announcement Date | 2/10/22 | 2/15/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1SEK in Million2NOK in Million3SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.13x | 6.61x | 14.64x | -.--% | 31.31B | |
| 98.25x | 82.99x | 98.12x | 0.39% | 15.19B | |
| 100.73x | 15.92x | 68.47x | 0.64% | 5.91B | |
| -35.1x | 9.91x | -53.67x | - | 2.41B | |
| -7.61x | 77.65x | -7.87x | - | 2.23B | |
| 55.17x | - | - | -.--% | 1.96B | |
| -122.07x | - | - | - | 1.14B | |
| 27.93x | 5.59x | 12.03x | 1.72% | 826M | |
| -91.51x | 1002.17x | -115.09x | -.--% | 756M | |
| Average | 6.21x | 171.55x | 2.38x | 0.46% | 6.86B | |
| Weighted average by Cap. | 46.20x | 43.00x | 36.32x | 0.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CARAO Stock
- APXZF Stock
- Valuation Carasent ASA
Select your edition
All financial news and data tailored to specific country editions
